TOWA Corporation provided consolidated earnings guidance for the year ending March 31, 2023. For the year, the company expects net sales of ¥55,000 million, operating profit of ¥12,200 million and profit attributable to owners of parent of ¥8,500 million or ¥339.88 basic earnings per share.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
11,270 JPY | -2.68% |
|
+0.45% | +58.06% |
06-06 | Luye Pharma's Japanese Partner Towa Files New Drug Application for Dementia Patch | MT |
05-21 | Jefferies Adjusts TOWA’s Price Target to 16,000 Yen From 12,000 Yen, Keeps at Buy | MT |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+58.06% | 1.69B | |
+43.25% | 194B | |
+76.73% | 40.49B | |
+48.31% | 36.64B | |
-16.11% | 28.33B | |
+30.05% | 23B | |
+12.83% | 12.67B | |
-6.52% | 12.09B | |
+191.41% | 11.99B | |
+55.95% | 6.72B |
- Stock Market
- Equities
- 6315 Stock
- News TOWA Corporation
- TOWA Corporation Provides Consolidated Earnings Guidance for the Year Ending March 31, 2023